| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.31B | 32.93B | 35.60B | 36.40B | 38.56B | 40.67B |
| Gross Profit | 8.46B | 7.20B | 8.23B | 8.22B | 10.08B | 12.49B |
| EBITDA | 6.91B | 5.54B | 6.77B | 6.53B | 7.95B | 9.60B |
| Net Income | 1.80B | 1.16B | 1.37B | 1.16B | 2.26B | 3.61B |
Balance Sheet | ||||||
| Total Assets | 39.66B | 38.39B | 41.69B | 42.80B | 43.54B | 43.47B |
| Cash, Cash Equivalents and Short-Term Investments | 17.62B | 18.30B | 19.52B | 18.38B | 17.91B | 19.17B |
| Total Debt | 1.38B | 945.13M | 2.52B | 4.07B | 4.69B | 4.49B |
| Total Liabilities | 10.48B | 8.16B | 10.62B | 11.85B | 13.01B | 13.90B |
| Stockholders Equity | 29.18B | 30.23B | 29.78B | 29.67B | 29.24B | 28.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.80B | 4.66B | 2.64B | 224.31M | 5.04B |
| Operating Cash Flow | 0.00 | 4.88B | 6.34B | 5.70B | 4.04B | 9.37B |
| Investing Cash Flow | 0.00 | -2.42B | -2.52B | -3.60B | -4.34B | -4.74B |
| Financing Cash Flow | 0.00 | -3.71B | -2.68B | -1.64B | -974.83M | 881.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥13.62B | 13.76 | ― | 2.82% | 7.70% | -12.71% | |
66 Neutral | ¥10.81B | 5.65 | ― | ― | 14.45% | 56.01% | |
62 Neutral | ¥30.49B | 26.24 | ― | 2.48% | -7.50% | -14.87% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥17.04B | 17.04 | ― | 2.53% | 6.14% | 19.31% | |
52 Neutral | ¥9.87B | 190.67 | ― | 5.06% | ― | ― | |
43 Neutral | ¥1.91B | -10.05 | ― | ― | -6.78% | -110.78% |